SNX proteins comprise a large group of proteins that contain a conserved PX (or phagocyte oxidase homology) domain targeting SNX proteins to endosomes 1 . SNX27 was originally identified in rats as an alternative splicing product of the Mrt1 (methamphetamine responsive transcript 1) gene 2 . SNX27 contains a PDZ (PSD-95, Disc-large and ZO-1) domain, making it unique among the PX domain proteins. PDZ domains are protein-protein interaction domains that are often found in the postsynaptic density (PSD) of neuronal excitatory synapses.
SNX27 reportedly participates in the dynamic trafficking of receptors and ion channels such as β2-adrenergic receptors (β2-ARs) 3, 4 , G protein-activated inward rectifying potassium type 2 (GIRK2) 5 , serotonin receptor subunit 4a (5-HT4a) 6 and NMDA-type glutamate receptor subunit 2C (NR2C) 7 . However, the physiological role of SNX27 at synapses and whether SNX27 regulates the trafficking of other major types of glutamate receptors remains unknown.
In the PSDs of excitatory synapses, different classes of glutamate receptors are responsible for transducing the presynaptic signal into both biochemical and electrical events in the postsynaptic neuron. The two major types of glutamate receptors are AMPA-type glutamate receptors (AMPARs) and NMDA receptors (NMDARs). Dysregulation of AMPARs and NMDARs is involved in several neurodegenerative diseases 8,9 . Down's syndrome, or trisomy 21, is a congenital disorder that manifests as defects in multiple organs and causes developmental delays and learning disabilities. People with Down's syndrome have an extra copy of chromosome 21, leading to an overdosage of the gene products and noncoding RNAs encoded by this chromosome. Down's syndrome pathology includes neuropathology of the cortex and hippocampus in both developmental and aging processes. Substantial dendritic and synaptic abnormalities, including decreased dendritic arborization 10 and a reduction in synaptic number, have been observed in both prenatal 11, 12 and postnatal Down's syndrome brains 13 . The balance between excitatory and inhibitory synapses is reportedly impaired in the brains of both humans with Down's syndrome and mouse models of the disease 14, 15 . Impaired long-term potentiation (LTP) has also been detected in the hippocampal CA1 region of Ts65Dn mice 16, 17 , a widely used Down's syndrome mouse model. Although several chromosome 21-encoded products, such as β-amyloid precursor protein (APP), are thought to contribute to the pathology of Down's syndrome, the detailed molecular mechanisms remain largely unclear.
Here we demonstrate a new role for SNX27 in the dysregulation of synaptic function in Down's syndrome. We show that chromosome 21-encoded miR-155 targets and downregulates C/EBPβ, which is a transcription factor for SNX27. Thus, the lower amounts of C/EBPβ in Down's syndrome lead to reduced SNX27 expression. We show that SNX27 promotes recycling of AMPARs and NMDARs from early endosomes to the plasma membrane through direct PDZ binding and thus prevents their degradation. Deletion of Snx27 in mice results in synaptic dysfunction and cognitive deficits. Further, overexpressing Snx27 in the hippocampus of Ts65Dn mice reverses the impairments in receptor amounts and synaptic functions, as well as in hippocampus-dependent memory. Therefore, SNX27 is crucial for maintaining glutamate receptors through posttranslational mechanisms and is required for normal synaptic activity and memory formation.
RESULTS
Cortical and hippocampal pathology of Snx27 −/− mice We first examined the developmental expression pattern of Snx27 in postnatal mouse brains and found that Snx27 expression can be detected at postnatal day 0 (P0) and reaches a plateau at P7. The developmental expression pattern of Snx27 is similar to those of glutamate receptor, ionotropic, AMPA1 (GluR1, also known as Gria1) and glutamate receptor, ionotropic, NMDA1 (NR1, also called Grin1) ( Fig. 1a) . In situ hybridization results, as reported by the Allen Brain Atlas, revealed that Snx27 mRNA is highly expressed in the cortex, hippocampus and cerebellum ( Supplementary Fig. 1 ). To investigate the physiological function of Snx27, we analyzed Snx27 knockout mice and found that most Snx27 −/− mice were viable from birth until P14. Their growth rate then slowed, and the mice died by week 4 (data not shown).
Microscopic histological examination of Snx27 −/− brains revealed degenerating neurons in the cortex at P14, with reduced somal size and hyperchromicity ( Fig. 1b) .
Brain development during the early postnatal period involves increases in dendritic branching and synapse formation, both of which were greatly compromised in Snx27 −/− mice at P14. Although the orientation of the apical dendrites was unaffected, the total dendritic lengths of both cortical layer 5 and hippocampal CA1 neurons were substantially reduced. There was also a marked decrease in dendritic branching in cortical neurons ( Fig. 1c,d) .
Impaired learning and memory in Snx27 +/− mice Complete loss of Snx27 results in severe neuronal death and eventual lethality in mice, making it impossible to determine how Snx27 influences memory formation and synaptic function. However, Snx27 +/− mice are viable and have grossly normal neuroanatomy (Supplementary Fig. 2 ) and lifespan 7 compared to Snx27 +/+ littermates; thus, we examined the role of Snx27 in memory and synaptic function using Snx27 +/− mice.
As intellectual disability is a primary aspect of Down's syndrome, we assessed potential cognitive deficits in Snx27 +/− mice using behavioral tests. We first used the Barnes maze 18, 19 to assess learning and memory and found that Snx27 +/− mice made more errors at days 6-8 after training ( Fig. 2a ) and used less spatial strategies than Snx27 +/+ mice (Supplementary Fig. 3a ). Snx27 +/− mice did not spend significantly more time in the target quadrant than in other quadrants in the probe test ( Fig. 2b) . Furthermore, Snx27 +/− mice spent much less time exploring novel objects than familiar objects in the novel object recognition task compared to Snx27 +/+ mice (Fig. 2c) . We performed additional behavioral tasks to test for locomotor activity npg ( Supplementary Fig. 3b-d ) and visual disabilities ( Supplementary  Fig. 4a ) and found no differences between Snx27 +/+ and Snx27 +/− mice.
Impaired synaptic functions in Snx27 +/− mice We took extracellular recordings of hippocampal slices to examine LTP in the hippocampal CA1 region. Input-output response results showed that Snx27 +/− mice had decreased excitatory synaptic transmission compared to Snx27 +/+ mice (Fig. 2d) . The attenuation of basal synaptic transmission in Snx27 +/− mice may arise from a reduced number of synapses or defects in either presynaptic or postsynaptic function. To distinguish between these possibilities, we used a pairedpulse facilitation (PPF) paradigm to examine the regulation of synaptic activity through Ca 2+ -mediated presynaptic neurotransmitter release. We found that the PPF ratio was unchanged in Snx27 +/− brain slices compared to Snx27 +/+ controls ( Fig. 2e) . In contrast, when we recorded miniature excitatory postsynaptic currents (mEPSCs) from CA1 hippocampal neurons, the amplitude was significantly decreased in Snx27 +/− neurons compared to Snx27 +/+ neurons, whereas the frequency remained unaltered ( Fig. 2f-h) .
Given that the defect is postsynaptic, we reasoned that synaptic plasticity should also be disrupted. When we examined NMDARdependent synaptic plasticity in Snx27 +/− mice, we found that LTP induced by high-frequency trains (100 Hz for 1 s) was decreased compared to Snx27 +/+ controls ( Fig. 2i) . As the mEPSCs data represent AMPAR-mediated responses, and the induction of LTP is dependent on intact NMDAR activity, our electrophysiological data suggest that Snx27 +/mice have defects in both AMPAR-and NMDAR-dependent synaptic events.
Loss of SNX27 increases degradation of AMPARs and NMDARs
Using western blot analysis, we determined that Snx27 +/− mice had lower amounts of GluR1, GluR2, NR1, NR2A and NR2B in both synaptosomal membranes and PSD fractions compared to Snx27 +/+ littermates ( Fig. 3a) . We examined the total amounts of glutamate receptor subunits in the hippocampus and found that the amounts of GluR1, GluR2 and NR1, but not NR2A and NR2B, were decreased in Snx27 −/− mice compared to Snx27 +/+ mice at P1. However, by P14, the amounts of NR2A and NR2B were also decreased ( Supplementary Fig. 5 ). The amount of PSD-95 (also called Dlg4) was unaffected at both time points.
We performed quantitative RT-PCR to measure receptor mRNA amounts and found that they were unaffected in the hippocampus of Snx27 −/− mice compared to littermate controls ( Supplementary  Fig. 6 ). To determine whether SNX27 influences turnover of the receptors, we performed cycloheximide chase assays in HEK293 cells overexpressing either GluR1 (GluR1-HEK293) or both NR1 and NR2A (NR1-NR2A-HEK293). The turnover of both GluR1 and NR1 was markedly accelerated by the downregulation of SNX27 using siRNA (Fig. 3b,c) . Treatment of GluR1-HEK293 or NR1-NR2A-HEK293 cells with the proteasomal inhibitor lactacystin or MG132 in the presence of cycloheximide largely rescued the degradation of GluR1 and NR1 caused by SNX27 knockdown. Treatment with the lysosomal inhibitor leupeptin or NH 4 Cl also rescued receptor degradation, although to a lesser extent ( Fig. 3d,e ).
SNX27 promotes glutamate receptor recycling to cell surface
We found that both a recombinant SNX27 PDZ domain and fulllength SNX27 protein linked with GST can pull down glutamate receptors (GluR1, GluR2, NR1 and NR2A) but not the presynaptic vesicle protein synaptophysin from mouse brain lysates ( Fig. 4a) . We co-transfected Myc-tagged SNX27 and constructs expressing various glutamate receptors into HEK293T cells and verified their interaction by coimmunoprecipitation ( Fig. 4b) . Moreover, endogenous Snx27 coimmunoprecipitated with endogenous glutamate receptors from mouse brain lysates ( Fig. 4c ). npg Cell surface biotinylation experiments showed that overexpression of SNX27 resulted in increased cell surface amounts of GluR1 and NR1 in GluR1-HEK293 and NR1-NR2A-HEK293 cells (Fig. 4d) . Conversely, knockdown of SNX27 resulted in reduced cell surface expression of GluR1 and NR1 (Fig. 4e) . This effect was also evident in primary neurons; we found a decrease in cell surface expression of GluR1 and NR1 in primary neurons derived from Snx27 +/− mice (Fig. 4f) .
Relative synaptic receptor levels npg
The steady-state expression of cell surface receptors is the net result of both endocytosis and recycling of the receptors. As SNX27 did not influence the endocytosis of GluR1 (Supplementary Fig. 7) , we postulated that SNX27 affects the recycling of the receptors. To test this hypothesis, we carried out receptor recycling assays and found that overexpression of SNX27 decreased the amount of internalized biotinylated GluR1 in GluR1-HEK293 cells, indicating an accelerated recycling rate (Fig. 4g) . Consistent with these overexpression experiments, we found slower recycling of biotin-labeled GluR1 after treatment with SNX27 siRNA as compared to treatment with control siRNA (Fig. 4h) .
Reduction of SNX27 expression in Down's syndrome brains
We examined the amount of SNX27 in brain samples from humans with Down's syndrome and age-matched controls and found that both protein and mRNA amounts of SNX27 were markedly decreased in the cortex of individuals with Down's syndrome (Fig. 5) . Consistent with changes in SNX27, the amount of GluR1 was also decreased in Down's syndrome brains, whereas the amount of APP was markedly increased (Fig. 5a) . However, the amount of SNX27 was not altered in the cortex of humans with sporadic Alzheimer's disease compared to controls (Fig. 5b) . We also found that the amounts of both Snx27 and C/EBPβ were lower in the hippocampus of Ts65Dn mice than in wild-type (WT) controls (Supplementary Fig. 8a) . However, only Snx27, but not Cebpb, mRNA expression was reduced in the hippocampus of Ts65Dn mice (Supplementary Fig. 8b) .
Regulation of SNX27 by the miR-155-C/EBPb pathway
We next examined the expression of chromosome 21-derived microRNAs (miRNAs) in Down's syndrome cortices. Our findings were consistent with previous studies demonstrating increased expression of chromosome 21-encoded miRNAs in the brains of both humans with Down's syndrome and Ts65Dn mice 20, 21 ( Supplementary Figs. 8c and 9a) . Among these miRNAs, only miR-155 expression was negatively correlated with SNX27 mRNA expression ( Supplementary Fig. 9b ). We transfected a miR-155 mimic into human neuroblastoma MC-IXC cells and found decreased amounts of both SNX27 protein and mRNA (Fig. 5d,e ). However, we found no consensus miR-155 binding sites on the SNX27 3′ untranslated region, suggesting that SNX27 is not the direct target. We found a positive correlation between the amounts of C/EBPβ and SNX27 in the cerebral cortex of humans with Down's syndrome (Supplementary Fig. 9c ). Additionally, in silico analysis predicted several C/EBPβ binding sites in the SNX27 promoter npg region (Supplementary Fig. 10) , and the binding of miR-155 to the C/EBPβ 3′ untranslated region was recently reported 22 . We overexpressed an active isoform of C/EBPβ, liver-enriched activator protein (LAP2), in MC-IXC human neuroblastoma cells and found that SNX27 was significantly upregulated (Fig. 5f) . Moreover, we determined that the amount of Snx27 was decreased in the cortex and hippocampus of Cebpb −/− mice compared to Cebpb +/− controls (Fig. 5g) . A luciferase reporter assay using HeLa cells showed that overexpression of LAP2 enhanced the promoter activity of human SNX27, whereas overexpression of another C/EBPβ isoform, liver inhibitory protein (LIP), did not affect SNX27 promoter activity (Fig. 5h) . We carried out a chromatin immunoprecipitation (ChIP) assay and found that C/EBPβ binds to the endogenous SNX27 promoter in HEK293T cells (Fig. 5i) . npg SNX27 expression rescues synaptic deficits in Ts65Dn mice To test whether SNX27 expression could rescue the synaptic deficits and impaired learning and memory of Down's syndrome, we generated an adeno-associated virus type 1 (AAV1) containing human SNX27 complementary DNA (Fig. 6a) . Overexpression of human SNX27 increased the amounts of GluR1, GluR2, NR1, NR2A and NR2B in rat primary neurons (Supplementary Fig. 11 ). We next injected AAV-SNX27-internal ribosome entry site (IRES)-GFP or an AAV-GFP control bilaterally into the hippocampal CA1 area of 7-to 8-monthold Ts65Dn or WT mice and analyzed the subsequent behavioral changes (Fig. 6b,c) . Because CA1-specific deletion of NMDAR1 can result in impaired performance on novel object recognition tests 23 and Ts65Dn mice show impaired LTP and novel object recognition memory 24 , this test may allow for the evaluation of hippocampusdependent memory. Notably, the cognitive and LTP deficits in Ts65Dn mice 16, 24 were rescued by increased SNX27 expression in the hippocampus ( Fig. 6b-e ). All mice behaved normally on the optomotor test ( Supplementary Fig. 4b) , excluding the possible confounding effects of visual problems (because a small portion of Ts65Dn mice may become blind 25 ). Four weeks after injection of AAV-SNX27-IRES-GFP, the amounts of SNX27 were markedly higher in AAV-SNX27-IRES-GFP-injected Ts65Dn mice than in AAV-GFP-injected Ts65Dn mice (Fig. 6f) . In synaptosomal preparations from Ts65Dn and WT mice, the amounts of glutamate receptor subunits GluR1, NR1 and NR2B were lower in Ts65Dn mice than in WT mice ( Supplementary  Fig. 8d ). Reduced amounts of synaptosomal glutamate receptors were rescued by exogenous expression of SNX27 in the hippocampus of the Ts65Dn mice ( Fig. 6f) .
DISCUSSION
Substantial dendritic and synaptic abnormalities, such as decreased dendritic arborization and reduced synapse numbers, have been reported in both prenatal and postnatal Down's syndrome brains 13 . Similarly, dendritic growth and branching is greatly compromised in Snx27 −/− mice analyzed at early postnatal stages. The decreased dendritic length and branching suggest that Snx27 is essential for postnatal brain development.
Abnormalities in excitatory neurotransmission and cognitive function have been reported in humans with Down's syndrome, as well as in Down's syndrome mouse models 14, 15, 26 . Decreased LTP has been observed in both Ts65Dn and Tc1 Down's syndrome mouse models 16, 17, 26 . To investigate whether Snx27 deficiency results in synaptic and cognitive deficits, we used Snx27 +/− mice for electrophysiological and behavioral studies, as Snx27 −/− mice show severe neuropathology and early lethality. Additionally, the Snx27 +/− mouse model might better mimic the pathology of human Down's syndrome, which is caused by a partial loss of SNX27 expression only. mEPSC recordings reveal that AMPAR-mediated postsynaptic currents are reduced in the hippocampus of Snx27 +/− mice compared to controls. Furthermore, NMDAR-dependent Schaffer-collateral CA1 LTP induction is attenuated in Snx27 +/− mice, indicating a possible role for Snx27 in the LTP mechanism.
The balance between the insertion and internalization of AMPARs at the postsynaptic membrane is an important mechanism for regulating synaptic strength. Our biochemical and cell biological data show that SNX27 promotes NMDAR and AMPAR recycling back to the plasma membrane and is not involved in the internalization of these receptors.
In the future, it will be interesting to study whether SNX27 regulates the recycling of NMDARs and AMPARs in cooperation with other components of the trafficking machinery. For example, SNX27, similarly to SNX17, contains a C-terminal PX-FERM domain, and the FERM domain can reportedly associate with the activated Ras small GTPase 27 . It is still unclear, however, whether SNX27 interacts with the small GTPase to regulate the sorting and recycling of NMDARs and AMPARs. Additionally, the retromer complex has also been shown to regulate the transport of various cargos from the endosome to the trans-Golgi network and plasma membrane directly. Previous studies showed cooperation between SNX27 and the retromer complex in the regulation of β2-AR recycling 4 . Mutation and dysfunction of the retromer complex have been linked with neurodegenerative diseases, including Alzheimer's disease [28] [29] [30] [31] and Parkinson's disease 32, 33 , and thus further investigation on whether SNX27 regulates the recycling of AMPARs and NMDARs in a retromer-dependent manner will be interesting.
miR-155, encoded on chromosome 21 and thus overexpressed in Down's syndrome, is a negative regulator of C/EBPβ 22 . Previous studies have suggested that C/EBP is crucial for the consolidation of long-term memory in both invertebrates and mice [34] [35] [36] [37] . CEBPB is an evolutionarily conserved gene with a selective role in the consolidation of new memories in the hippocampus. Our results indicate that SNX27, a downstream target of C/EBPβ, is downregulated in Down's syndrome brains. Notably, restoration of SNX27 by site-specific delivery of AAV reverses the LTP and cognitive deficits of Ts65Dn mice. Loss of SNX27 may partially explain the mechanism whereby trisomy 21 leads to synaptic dysfunction and memory impairments.
We found nearly normal protein amounts of GABA A receptor subunits (α1 and β2) in the hippocampus of Snx27 +/− mice. Using coimmunoprecipitation, we also determined that SNX27 does not interact with GABA A receptor subunits (α1 and β2) (Supplementary Fig. 12) . These results suggest that SNX27 does not affect GABA A receptors. However, previous studies have reported that SNX27 negatively regulates GIRK2 (ref. 5) , which is encoded by chromosome 21 and is highly expressed in Down's syndrome brains. As GIRK2 controls the excitability of neurons through GIRK-mediated self inhibition, its overexpression is involved in the excessive inhibition in Down's syndrome brains 38, 39 . Therefore, SNX27 expression could contribute to the restoration of balance between excitation and inhibition through both upregulation of excitatory transmission and suppression of GIRK2-mediated inhibition.
In summary, we have identified a signaling pathway in which the decreased amount of C/EBPβ resulting from excessive miR-155 in Down's syndrome represses SNX27 expression (see Supplementary  Fig. 13 for a schematic model). This leads to synaptic dysfunction and neuropathological changes. Thus, the miR-155-C/EBPβ-SNX27 pathway is a newly identified contributory mechanism to the neuropathogenesis of Down's syndrome.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
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